Literature DB >> 11196724

Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

R L Eakin1, M I Saunders.   

Abstract

This paper reviews the use of hyperfractionated and/or accelerated radiation therapy in the curative treatment of non-small cell lung cancer, and explains the scientific rationale behind the development of these regimes. The indications, practicalities and economics of introducing them routinely are addressed. Novel radiotherapy techniques are further discussed in the context of current developments and on-going clinical trials.

Entities:  

Mesh：

Year:  2000        PMID： 11196724      PMCID： PMC2449197     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


  45 in total

1.  The Relation between the Mitochondria and Glucose-Glycogen Equilibrium in the Liver.

Authors:  E M Hall; E M Mackay
Journal:  Am J Pathol       Date:  1933-03       Impact factor: 4.307

2.  Radiobiologically based assessments of the net costs of fractionated radiotherapy.

Authors:  R G Dale; B Jones
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-10-01       Impact factor: 7.038

3.  Accelerated fractionation in esophageal cancers: a multivariate analysis on 88 patients.

Authors:  T Girinsky; A Auperin; H Marsiglia; F Dhermain; H Randrianarivelo; J Kac; M Ducreux; D Elias; P Rougier
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-07-15       Impact factor: 7.038

4.  Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.

Authors:  M E Powell; P J Hoskin; M I Saunders; C J Foy; S Dische
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-04-01       Impact factor: 7.038

5.  Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

Authors:  C A Perez; T F Pajak; P Rubin; J R Simpson; M Mohiuddin; L W Brady; R Perez-Tamayo; M Rotman
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

6.  Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

Authors:  M Stuschke; H D Thames
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-15       Impact factor: 7.038

7.  A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.

Authors:  S Dische; M Saunders; A Barrett; A Harvey; D Gibson; M Parmar
Journal:  Radiother Oncol       Date:  1997-08       Impact factor: 6.280

8.  Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.

Authors:  R Komaki; C B Scott; W T Sause; D H Johnson; S G Taylor; J S Lee; B Emami; R W Byhardt; W J Curran; A R Dar; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

9.  Initial experience with a practical hyperfractionated accelerated radiotherapy regimen.

Authors:  A Herskovic; C Orton; M Seyedsadr; P Lattin; M Kraut; I Han; S Han; K Ahmad; J Holt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

10.  Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer.

Authors:  M V Graham; J A Purdy; B Emami; J W Matthews; W B Harms
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-12-01       Impact factor: 7.038
View more
  1 in total

1.  A meta-analysis comparing hyperfractionated vs. conventional fractionated radiotherapy in non-small cell lung cancer.

Authors:  Weisan Zhang; Qian Liu; Xifeng Dong; Ping Lei
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.